Skip to main content

Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds

Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.